Int. J. Mol. Sci. 2012, 13(1), 221-239; doi:10.3390/ijms13010221
Review

Molecular Basis of Medullary Thyroid Carcinoma: The Role of RET Polymorphisms

email, email, email, email and * email
Received: 10 October 2011; in revised form: 29 November 2011 / Accepted: 20 December 2011 / Published: 27 December 2011
(This article belongs to the Special Issue Advances in Molecular Diagnostics)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Medullary thyroid carcinoma is a rare malignant tumor originating in parafollicular C cells. It accounts for 5 to 8% of all thyroid cancers. MTC develops in either sporadic (75%) or hereditary form (25%). Genetic and molecular studies have demonstrated the involvement of the RET proto-oncogene in hereditary MTC and, less often, in its sporadic form. Although a strong genotype-phenotype correlation has been described, wide clinical heterogeneity is observed among families with the same RET mutation or even in carriers of the same kindred. In recent years, several single nucleotide polymorphisms of the RET gene have been described in the general population as well as in patients with MTC. Some studies have reported associations between the presence of polymorphisms and development or progression of MTC. Nonetheless, other studies failed to demonstrate any effect of the RET variants. Differences in the genetic background of distinct populations or methodological approaches have been suggested as potential reasons for the conflicting results. Here, we review current knowledge concerning the molecular pathogenesis of sporadic and hereditary MTC. In particular, we analyze the role of RET polymorphisms in the clinical presentation and prognosis of MTC based on the current literature.
Keywords: medullary thyroid carcinoma; RET polymorphisms; prognosis
PDF Full-text Download PDF Full-Text [341 KB, uploaded 19 June 2014 04:09 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Ceolin, L.; Siqueira, D.R.; Romitti, M.; Ferreira, C.V.; Maia, A.L. Molecular Basis of Medullary Thyroid Carcinoma: The Role of RET Polymorphisms. Int. J. Mol. Sci. 2012, 13, 221-239.

AMA Style

Ceolin L, Siqueira DR, Romitti M, Ferreira CV, Maia AL. Molecular Basis of Medullary Thyroid Carcinoma: The Role of RET Polymorphisms. International Journal of Molecular Sciences. 2012; 13(1):221-239.

Chicago/Turabian Style

Ceolin, Lucieli; Siqueira, Débora R.; Romitti, Mírian; Ferreira, Carla V.; Maia, Ana Luiza. 2012. "Molecular Basis of Medullary Thyroid Carcinoma: The Role of RET Polymorphisms." Int. J. Mol. Sci. 13, no. 1: 221-239.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert